Statistics
Publications
1
Citations
12
H-Index
1
Active since
2022
Affiliations
Blueprint Medicines (United States)(Current)
Phil Ramsden is an author at Blueprint Medicines (United States) specializing in cdk inhibitors, cyclin-dependent kinase inhibitors, and cell-cycle dysregulation.
Publications per year
2022–2022
1
1
1–1 of 1